Browse by Title

Type here to filter the list

D
Data to Action: Leveraging Drug Utilization Research to Shift Clinical Practice and Health Policy

Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto ### 1062862###Lead Speaker###Assistant Professor###University of Toronto###
Lead Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet ### 1358115###Speaker###Assistant professor###Syddansk Universitet###
Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
### @@@ Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1655344###Speaker###Assistant Professor###University of North Carolina at Chapel Hill###
Speaker: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Gillian E. Caughey, PhD – Registry of Senior Australians, South Australian Health and Medical Research Institute ### 1655998###Speaker###Associate Director###Registry of Senior Australians, South Australian Health and Medical Research Institute###
Speaker: Gillian E. Caughey, PhD – Registry of Senior Australians, South Australian Health and Medical Research Institute
###
Decreased Discontinuation and Switching of b/tsDMARDs in RA When Treatment Aligns with Molecular Signature Response Classifier Results: An Analysis from The Study to Accelerate Information of Molecular Signatures (AIMS)

Jeffrey R. Curtis, MD, MS, MPH (he/him/his) – University of Alabama at Birmingham ### 1359630###Presenting Author###Professor of Medicine, Epidemiology and Computer Science###University of Alabama at Birmingham###
Presenting Author: Jeffrey R. Curtis, MD, MS, MPH (he/him/his) – University of Alabama at Birmingham
### he/him/his @@@ Lixia zhang – Scipher Medicine Corporation ### 1991730###Co-Author######Scipher Medicine Corporation###
Co-Author: Lixia zhang – Scipher Medicine Corporation
### @@@ Johanna Withers – Scipher Medicine Corporation ### 1991731###Co-Author######Scipher Medicine Corporation###
Co-Author: Johanna Withers – Scipher Medicine Corporation
### @@@ Sam Asgarian, MD MBA – Scipher Medicine Corporation ### 1991732###Co-Author###Chief Medical Officer###Scipher Medicine Corporation###
Co-Author: Sam Asgarian, MD MBA – Scipher Medicine Corporation
###
Deep Learning for Pharmacoepidemiologists: An Accessible Introduction to Neural Networks

Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA ### 1653783###Lead Speaker###Associate Director of Epidemiology###IQVIA###
Lead Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hers @@@ Harriet Dickinson, MPhil, PhD – Gilead ### 1991252###Speaker###RWE Director###Gilead###
Speaker: Harriet Dickinson, MPhil, PhD – Gilead
### @@@ Orla M. Doyle, PhD, BEng – Novartis ### 1088162###Speaker###Director Data Science###Novartis###
Speaker: Orla M. Doyle, PhD, BEng – Novartis
### @@@ Dana Y. Teltsch, PhD, MSc – Takeda ### 1088160###Speaker###Global Medical Evidence###Takeda###
Speaker: Dana Y. Teltsch, PhD, MSc – Takeda
### @@@ Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA ### 1063015###Speaker###Chief Scientific Officer, IQVIA RWS###IQVIA###
Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
### she/her/hers
Defining Post-COVID Conditions Using Changes in Symptomatology in Electronic Health Record Data from the United States

Kathleen M. Andersen, PhD (she/her/hers) – Pfizer ### 1723628###Presenting Author###Director, Vaccines Real World Evidence###Pfizer###
Presenting Author: Kathleen M. Andersen, PhD (she/her/hers) – Pfizer
### she/her/hers @@@ Farid L. Khan – Pfizer ### 1991187###Co-Author######Pfizer###
Co-Author: Farid L. Khan – Pfizer
### @@@ Peter W. Park – Pfizer ### 1991188###Co-Author######Pfizer###
Co-Author: Peter W. Park – Pfizer
### @@@ Timothy L. Wiemken, PhD – Pfizer ### 1991189###Co-Author###Senior Director, Global Clinical Epidemiology###Pfizer###
Co-Author: Timothy L. Wiemken, PhD – Pfizer
### @@@ Birol Emir, PhD – Pfizer Inc ### 1991190###Co-Author######Pfizer Inc###
Co-Author: Birol Emir, PhD – Pfizer Inc
### @@@ Deepa Malhotra, MS, MBA – Pfizer ### 1657486###Co-Author###Senior Director, Global RWE Lead, Vaccines###Pfizer###
Co-Author: Deepa Malhotra, MS, MBA – Pfizer
### @@@ Tuka Alhanai – Ghamut Corporation ### 1991191###Co-Author######Ghamut Corporation###
Co-Author: Tuka Alhanai – Ghamut Corporation
### @@@ Mohammad Ghassemi – Ghamut Corporation ### 1991192###Co-Author######Ghamut Corporation###
Co-Author: Mohammad Ghassemi – Ghamut Corporation
### @@@ Leah J. McGrath, PhD – Pfizer ### 1659611###Co-Author###Senior Director, Vaccines RWE###Pfizer###
Co-Author: Leah J. McGrath, PhD – Pfizer
###
Depressive Symptoms and Polypharmacy Among Adults: A Population-Based Analysis Using National Health and Nutrition Examination Survey (NHANES) Data

Elyse M. Miller, MPH (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health ### 1660169###Presenting Author###Doctoral Student###UNC Chapel Hill Gillings School of Global Public Health###
Presenting Author: Elyse M. Miller, MPH (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health
### she/her/hers @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health ### 1046824###Co-Author###Associate Professor###UNC Chapel Hill Gillings School of Global Public Health###
Co-Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health
### she/her/hers
Determinants of non-compliance with the pregnancy prevention program in women initiating oral isotretinoin therapy: a cohort study from the French nationwide claims database

Anaïs Havet, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ### 1991152###Presenting Author###Researcher in pharmacoepidemiology###Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France###
Presenting Author: Anaïs Havet, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France
### @@@ Clara Bouvard, MSc (she/her/hers) – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ### 1991153###Co-Author###Biostatistician###Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France###
Co-Author: Clara Bouvard, MSc (she/her/hers) – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France
### she/her/hers @@@ Aurélie Moskal, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ### 1991154###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France###
Co-Author: Aurélie Moskal, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France
### @@@ Marc Chanelière, MD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Collège universitaire de Médecine Générale, Université Lyon 1, Villeurbanne, France ### 1991155###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Collège universitaire de Médecine Générale, Université Lyon 1, Villeurbanne, France###
Co-Author: Marc Chanelière, MD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Collège universitaire de Médecine Générale, Université Lyon 1, Villeurbanne, France
### @@@ Jérôme Massardier, MD – Service de Gynécologie-Obstétrique, Hospices Civils de Lyon, hôpital Femme-Mère-Enfant, Lyon, France ### 1991156###Co-Author######Service de Gynécologie-Obstétrique, Hospices Civils de Lyon, hôpital Femme-Mère-Enfant, Lyon, France###
Co-Author: Jérôme Massardier, MD – Service de Gynécologie-Obstétrique, Hospices Civils de Lyon, hôpital Femme-Mère-Enfant, Lyon, France
### @@@ Bénédicte Lebrun-Vignes, MD – Service de Pharmacologie, Centre Régional de Pharmacovigilance, Hôpital Pitié-Salpêtrière, AP-HP, GH Sorbonne Université, Paris, France ### 1991157###Co-Author######Service de Pharmacologie, Centre Régional de Pharmacovigilance, Hôpital Pitié-Salpêtrière, AP-HP, GH Sorbonne Université, Paris, France###
Co-Author: Bénédicte Lebrun-Vignes, MD – Service de Pharmacologie, Centre Régional de Pharmacovigilance, Hôpital Pitié-Salpêtrière, AP-HP, GH Sorbonne Université, Paris, France
### @@@ Annie Pierre E. JONVILLE-BERA, MD – Centre Régional de Pharmacovigilance, CHRU de Tours, Hôpital Bretonneau, Tours, France ### 1991158###Co-Author###physician, head of department###Centre Régional de Pharmacovigilance, CHRU de Tours, Hôpital Bretonneau, Tours, France###
Co-Author: Annie Pierre E. JONVILLE-BERA, MD – Centre Régional de Pharmacovigilance, CHRU de Tours, Hôpital Bretonneau, Tours, France
### @@@ Cécile Payet, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 1991159###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###
Co-Author: Cécile Payet, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Marie Viprey, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 1991160###Co-Author###Deputy head of the health data department of the Hospices Civils de Lyon###Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###
Co-Author: Marie Viprey, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
###
Developing Clinically Interpretable Machine Learning Algorithms for Pressure Injury Safety Surveillance with Explainable AI

Jenny Alderden – Boise State ### 1991741###Co-Author######Boise State###
Co-Author: Jenny Alderden – Boise State
### @@@ Jace Johnny – University of Utah ### 1991742###Co-Author######University of Utah###
Co-Author: Jace Johnny – University of Utah
### @@@ Andy Wilson, PhD – Parexel ### 1093652###Presenting Author###Head of Innovative RWD Analytics###Parexel###
Presenting Author: Andy Wilson, PhD – Parexel
###
Developing Code Lists for Pharmacoepidemiology: The How and Why?

Sina Noshad – Genesis Research ### 1991186###Lead Speaker######Genesis Research###
Lead Speaker: Sina Noshad – Genesis Research
### @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Speaker###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###
Speaker: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his @@@ Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc. ### 1991390###Speaker###Executive Director, Head of Epidemiology and Risk Management Operation###BeiGene USA, Inc.###
Speaker: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.
### he/him/his @@@ Asieh Golozar, MD PhD MHS MPH – Odysseus Data Services Inc. ### 1062692###Speaker###VP, Global Head of Data Science ###Odysseus Data Services Inc.###
Speaker: Asieh Golozar, MD PhD MHS MPH – Odysseus Data Services Inc.
### @@@ Susan A. Oliveria, ScD, MPH, FISPE – PPD, a part of Thermo Fisher Scientific ### 1991428###Speaker###Vice-President, Global Head Epidemiology and Scientific Affairs###PPD, a part of Thermo Fisher Scientific###
Speaker: Susan A. Oliveria, ScD, MPH, FISPE – PPD, a part of Thermo Fisher Scientific
###
Development and evaluation of phenotype algorithms for the European Medicines Agency designated medical events in a network of real-world data

Azza Shoaibi, PhD, MPH – Janssen Research & Development ### 1360292###Presenting Author###Associate director ###Janssen Research & Development###
Presenting Author: Azza Shoaibi, PhD, MPH – Janssen Research & Development
### @@@ Gowtham Rao – Janssen Research & Development ### 1360293###Co-Author######Janssen Research & Development###
Co-Author: Gowtham Rao – Janssen Research & Development
### @@@ Joel N. Swerdel, PhD MS MPH (he/him/his) – Janssen Pharmaceuticals, Inc. ### 1659127###Co-Author###Director###Janssen Pharmaceuticals, Inc.###
Co-Author: Joel N. Swerdel, PhD MS MPH (he/him/his) – Janssen Pharmaceuticals, Inc.
### he/him/his @@@ Ruth Namuyinga – Janssen RND ### 1994081###Co-Author######Janssen RND###
Co-Author: Ruth Namuyinga – Janssen RND
### @@@ Santhi Mantravadi – Janssen RND ### 1994083###Co-Author######Janssen RND###
Co-Author: Santhi Mantravadi – Janssen RND
### @@@ Brigitte Schaufelberger – Janssen RND ### 1994084###Co-Author######Janssen RND###
Co-Author: Brigitte Schaufelberger – Janssen RND
### @@@ Nancy Parker, MD – Janssen RND ### 1994085###Co-Author######Janssen RND###
Co-Author: Nancy Parker, MD – Janssen RND
### @@@ Eva De la torre – Janssen RND ### 1994086###Co-Author######Janssen RND###
Co-Author: Eva De la torre – Janssen RND
### @@@ Susan Sabol – Janssen RND ### 1994087###Co-Author######Janssen RND###
Co-Author: Susan Sabol – Janssen RND
### @@@ Evan Minty, MD MSc – University of Calgary ### 1994080###Co-Author###Clinical Assistant Professor###University of Calgary###
Co-Author: Evan Minty, MD MSc – University of Calgary
### @@@ Dmytro Dymshyts – Janssen RND ### 1994088###Co-Author######Janssen RND###
Co-Author: Dmytro Dymshyts – Janssen RND
### @@@ Amy Purrington – Janssen RND ### 1994082###Co-Author######Janssen RND###
Co-Author: Amy Purrington – Janssen RND
### @@@ Patrick B. Ryan, PhD – Johnson & Johnson ### 1661016###Co-Author######Johnson & Johnson###
Co-Author: Patrick B. Ryan, PhD – Johnson & Johnson
###
Diagnosing informative left truncation due to delayed cohort entry in clinico-genomic real-world data

Jonas Walheim, PhD (he/him/his) – Bristol Myers Squibb ### 1991167###Presenting Author###Senior Scientist###Bristol Myers Squibb###
Presenting Author: Jonas Walheim, PhD (he/him/his) – Bristol Myers Squibb
### he/him/his @@@ Nives Rombini – Bristol Myers Squibb ### 1991169###Co-Author######Bristol Myers Squibb###
Co-Author: Nives Rombini – Bristol Myers Squibb
### @@@ Kim Van Naarden Braun, PhD – Bristol Myers Squibb ### 1991168###Co-Author###Senior Scientific Director###Bristol Myers Squibb###
Co-Author: Kim Van Naarden Braun, PhD – Bristol Myers Squibb
###
Differences in Urinary Tract Infection Incidence During Pregnancy by Racial and Ethnic Group in an Integrated Health System in the US, 2010-2022

Paige D. Wartko, PhD, MPH – Kaiser Permanente Washington Health Research Institute ### 1063317###Presenting Author###Collaborative Scientist II###Kaiser Permanente Washington Health Research Institute###
Presenting Author: Paige D. Wartko, PhD, MPH – Kaiser Permanente Washington Health Research Institute
### @@@ Sharon Fuller, BA – Kaiser Permanente Washington Health Research Institute ### 1360112###Co-Author###Programmer###Kaiser Permanente Washington Health Research Institute###
Co-Author: Sharon Fuller, BA – Kaiser Permanente Washington Health Research Institute
### @@@ Anne M. Butler, PhD, MS (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1062638###Co-Author###Assistant Professor###Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###
Co-Author: Anne M. Butler, PhD, MS (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### she/her/hers @@@ Susan M. Shortreed, PhD, MS – Kaiser Permanente Washington Health Research Institute ### 1360508###Co-Author###Senior Scientific Investigator###Kaiser Permanente Washington Health Research Institute###
Co-Author: Susan M. Shortreed, PhD, MS – Kaiser Permanente Washington Health Research Institute
### @@@ Michael J. Durkin, MD, MPH – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1655836###Co-Author######Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###
Co-Author: Michael J. Durkin, MD, MPH – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### @@@ Sarah S. Osmundson, MD, MS – Department of Obstetrics and Gynecology, Vanderbilt University Medical Center ### 1359344###Co-Author###Associate Professor###Department of Obstetrics and Gynecology, Vanderbilt University Medical Center###
Co-Author: Sarah S. Osmundson, MD, MS – Department of Obstetrics and Gynecology, Vanderbilt University Medical Center
### @@@ Katelin B. Nickel, MPH (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine ### 1655835###Co-Author###Sr. programmer analyst###Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine###
Co-Author: Katelin B. Nickel, MPH (she/her/hers) – Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine
### she/her/hers @@@ Sandra McAteer – Department of Epidemiology, University of Washington, Seattle, WA, USA ### 1991533###Co-Author######Department of Epidemiology, University of Washington, Seattle, WA, USA###
Co-Author: Sandra McAteer – Department of Epidemiology, University of Washington, Seattle, WA, USA
### @@@ Robin Garcia, MPH – Kaiser Permanente Washington Health Research Institute ### 1991241###Co-Author######Kaiser Permanente Washington Health Research Institute###
Co-Author: Robin Garcia, MPH – Kaiser Permanente Washington Health Research Institute
### @@@ Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute ### 1062553###Co-Author###Senior Scientific Investigator###Kaiser Permanente Washington Health Research Institute###
Co-Author: Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute
###
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Biliary Tract Diseases Among Patients With Type 2 Diabetes

Samantha B. Shapiro, MSc, BSc – McGill University ### 1659403###Presenting Author###PhD Candidate###McGill University###
Presenting Author: Samantha B. Shapiro, MSc, BSc – McGill University
### @@@ Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada ### 1397870###Co-Author######The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada###
Co-Author: Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada
### @@@ Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada ### 1358432###Co-Author###Assistant Professor###Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada###
Co-Author: Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada
### @@@ Laurent Azoulay, PhD – McGill University ### 1302855###Co-Author###Associate Professor###McGill University###
Co-Author: Laurent Azoulay, PhD – McGill University
###
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Skin Cancer Among Patients with Type 2 Diabetes: Population-Based Cohort Study

Richeek Pradhan, MD, MS, PhD (he/him/his) – Harvard Medical School and Brigham and Women's Hospital ### 1062660###Presenting Author###Postdoctoral fellow###Harvard Medical School and Brigham and Women's Hospital###
Presenting Author: Richeek Pradhan, MD, MS, PhD (he/him/his) – Harvard Medical School and Brigham and Women's Hospital
### he/him/his @@@ Laurent Azoulay, PhD – McGill University ### 1302855###Co-Author###Associate Professor###McGill University###
Co-Author: Laurent Azoulay, PhD – McGill University
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Co-Author###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Co-Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada ### 1358432###Co-Author###Assistant Professor###Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada###
Co-Author: Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada
###
Disorders of glycemic control in child following exposure to antibiotics: a nationwide cohort study

Eun-Young Choi, PharmD – School of Pharmacy, Sungkyunkwan University ### 1655650###Presenting Author###PhD student###School of Pharmacy, Sungkyunkwan University###
Presenting Author: Eun-Young Choi, PharmD – School of Pharmacy, Sungkyunkwan University
### @@@ Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1358246###Co-Author###Doctoral student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Disparities in the Uptake of Newer Second-Line Antidiabetic Therapies among Medicare Beneficiaries

Eric Wang, PharmD – Center for Pharmacoepidemiology and Treatment Sciences, Rutgers University/ Daiichi Sankyo, Inc. ### 1658646###Presenting Author###Manager###Center for Pharmacoepidemiology and Treatment Sciences, Rutgers University/ Daiichi Sankyo, Inc.###
Presenting Author: Eric Wang, PharmD – Center for Pharmacoepidemiology and Treatment Sciences, Rutgers University/ Daiichi Sankyo, Inc.
### @@@ Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1360380###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###
Co-Author: Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### she/her/hers @@@ Stephen Crystal, Ph.D. – Rutgers University ### 1358692###Co-Author###Board of Governors Professor###Rutgers University###
Co-Author: Stephen Crystal, Ph.D. – Rutgers University
### @@@ Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Co-Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###
Co-Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
###
Does Misclassification due to Electronic Health Record Discontinuity Cause Biased Effect Estimates in Comparative Effectiveness Research?

Yinzhu Jin, MPH (she/her/hers) – Brigham and Women's Hospital ### 1062667###Presenting Author###Research Specialist###Brigham and Women's Hospital###
Presenting Author: Yinzhu Jin, MPH (she/her/hers) – Brigham and Women's Hospital
### she/her/hers @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###
Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1093509###Co-Author###Assistant Professor ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###
Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
###
Don't Lose Heart

Elena Rivero-Ferrer, MD, MPH, FISPE (she/her/hers) – RTI Health Solutions ### 1092305###Co-Moderator###Senior Director, Epidemiology###RTI Health Solutions###
Co-Moderator: Elena Rivero-Ferrer, MD, MPH, FISPE (she/her/hers) – RTI Health Solutions
### she/her/hers @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1659086###Co-Moderator###Senior Epidemiologist###Optum Epidemiology###
Co-Moderator: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers
Drug Safety in Diabetes

Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Co-Moderator###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###
Co-Moderator: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1360408###Co-Moderator###Director, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc., Tarrytown, NY###
Co-Moderator: Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### he/him/his
Drug utilisation of valproate-containing medicinal products in women of childbearing potential in 5 European countries: a population-based network cohort study part of DARWIN EU®

Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1360474###Presenting Author###Senior Researcher in Public Health and Epidemiology###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Presenting Author: Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1659148###Co-Author###Senior Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### he/him/his @@@ Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University ### 1092267###Co-Author###Associate Professor###Department of Medical Informatics, Erasmus MC University###
Co-Author: Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University
### she/her/hers @@@ Maria de Ridder – Erasmus University Medical Center ### 1360078###Co-Author######Erasmus University Medical Center###
Co-Author: Maria de Ridder – Erasmus University Medical Center
### @@@ Carlen Reyes Reyes – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1655367###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Carlen Reyes Reyes – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Talita Duarte-Salles, PhD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991455###Co-Author######Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Talita Duarte-Salles, PhD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center ### 1094832###Co-Author###Professor Medical Informatics###Department of Medical Informatics, Erasmus University Medical Center###
Co-Author: Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center
### @@@ Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358374###Co-Author###Senior Researcher###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Co-Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###
Co-Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers
Due Before, During, and After Pregnancy

Ursula Kirchmayer, MPH, FISPE – Department of Epidemiology, Lazio Regional Health Service, Rome ### 1302759###Co-Moderator###MPH, FISPE###Department of Epidemiology, Lazio Regional Health Service, Rome###
Co-Moderator: Ursula Kirchmayer, MPH, FISPE – Department of Epidemiology, Lazio Regional Health Service, Rome
### @@@ Cécile Droz-Perroteau – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France ### 1358269###Co-Moderator######Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France###
Co-Moderator: Cécile Droz-Perroteau – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France
###